| Jennifer Lynn Kruger, MD | |
|
2929 5th Street, 240, Rapid City, SD 57701 | |
| (605) 341-3770 | |
| (605) 341-8692 |
| Full Name | Jennifer Lynn Kruger |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 18 Years |
| Location | 2929 5th Street, Rapid City, South Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396953774 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 8131 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Monument Health Rapid City Hospital | Rapid city, SD | Hospital |
| Chadron Community Hospital And Health Services | Chadron, NE | Hospital |
| Monument Health Spearfish Hospital | Spearfish, SD | Hospital |
| Monument Health Sturgis Hospital | Sturgis, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Monument Health Rapid City Hospital, Inc. | 6002729506 | 424 |
News Archive
Cyclacel Pharmaceuticals, Inc., today announced the publication of preclinical data in the Proceedings of the National Academy of Sciences (PNAS), demonstrating that cyclin E plays a major role in making Human Epidermal growth factor Receptor 2 positive (HER2+) breast cancer resistant to trastuzumab (Herceptin®), a widely used medicine for breast cancer patients who test positive for HER2.
Approximately four in five people living with hepatitis B and three out of four people with hepatitis C infection across the European Union and European Economic Area (EU/EEA) and the UK have not yet been diagnosed.
Oxford University Press (OUP) is pleased to announce that it will be publishing Japan's pre-eminent title in radiation science from next year.
Tomorrow (Friday, June 11), Family Research Council Senior Fellow Peter Sprigg will testify before the Advisory Committee on Blood Safety and Availability (ACBSA) of the Department of Health and Human Services.
› Verified 3 days ago
| Entity Name | Monument Health Rapid City Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275553463 PECOS PAC ID: 6002729506 Enrollment ID: O20070625000144 |
News Archive
Cyclacel Pharmaceuticals, Inc., today announced the publication of preclinical data in the Proceedings of the National Academy of Sciences (PNAS), demonstrating that cyclin E plays a major role in making Human Epidermal growth factor Receptor 2 positive (HER2+) breast cancer resistant to trastuzumab (Herceptin®), a widely used medicine for breast cancer patients who test positive for HER2.
Approximately four in five people living with hepatitis B and three out of four people with hepatitis C infection across the European Union and European Economic Area (EU/EEA) and the UK have not yet been diagnosed.
Oxford University Press (OUP) is pleased to announce that it will be publishing Japan's pre-eminent title in radiation science from next year.
Tomorrow (Friday, June 11), Family Research Council Senior Fellow Peter Sprigg will testify before the Advisory Committee on Blood Safety and Availability (ACBSA) of the Department of Health and Human Services.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Lynn Kruger, MD 353 Fairmont Blvd, Atten Medical Staff Services, Rapid City, SD 57701-6000 Ph: () - | Jennifer Lynn Kruger, MD 2929 5th Street, 240, Rapid City, SD 57701 Ph: (605) 341-3770 |
News Archive
Cyclacel Pharmaceuticals, Inc., today announced the publication of preclinical data in the Proceedings of the National Academy of Sciences (PNAS), demonstrating that cyclin E plays a major role in making Human Epidermal growth factor Receptor 2 positive (HER2+) breast cancer resistant to trastuzumab (Herceptin®), a widely used medicine for breast cancer patients who test positive for HER2.
Approximately four in five people living with hepatitis B and three out of four people with hepatitis C infection across the European Union and European Economic Area (EU/EEA) and the UK have not yet been diagnosed.
Oxford University Press (OUP) is pleased to announce that it will be publishing Japan's pre-eminent title in radiation science from next year.
Tomorrow (Friday, June 11), Family Research Council Senior Fellow Peter Sprigg will testify before the Advisory Committee on Blood Safety and Availability (ACBSA) of the Department of Health and Human Services.
› Verified 3 days ago
Steven K Hata, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2929 5th Street, 240, Rapid City, SD 57701 Phone: 605-341-3770 Fax: 605-341-8692 | |
Dr. Douglas Thorburn Brown, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2929 5th Street, 240, Rapid City, SD 57701 Phone: 605-341-3770 Fax: 605-341-8692 | |
Kirsten A Butz, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 915 Mt View Rd, Rapid City, SD 57702 Phone: 605-755-7300 Fax: 605-755-0707 | |
Dr. Terry R Hicks, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 350 Elk St, Rapid City, SD 57701 Phone: 605-343-7262 Fax: 605-343-7293 | |
Dr. Ryan Gianatasio, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 677 Cathedral Dr, Rapid City, SD 57701 Phone: 605-755-4150 | |
Dr. Mark Thomas Garry, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10 Van Buren St, Rapid City, SD 57701 Phone: 605-721-8939 | |
Heather G Cwach, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2929 5th Street, 240, Rapid City, SD 57701 Phone: 605-341-3770 Fax: 605-341-8692 |